Literature DB >> 26355738

Overweight and obesity in children with newly diagnosed inflammatory bowel disease.

Aleksandra Pituch-Zdanowska1, Aleksandra Banaszkiewicz2, Marcin Dziekiewicz2, Izabella Łazowska-Przeorek2, Agnieszka Gawrońska2, Kinga Kowalska-Duplaga3, Barbara Iwańczak4, Beata Klincewicz5, Urszula Grzybowska-Chlebowczyk6, Jarosław Walkowiak5, Piotr Albrecht2.   

Abstract

PURPOSE: Determination of overweight and obesity prevalence in children with inflammatory bowel disease (IBD) at the time of diagnosis.
MATERIAL AND METHODS: This was a multicenter retrospective study. The study group consisted of children with new cases of IBD diagnosed in 2005-2013 according to the Porto criteria. Hospital admission records were reviewed for demographic and clinical characteristics. BMI-for-age and gender percentile charts were used to define overweight as ≥85th BMI percentile and obesity as ≥95th BMI percentile.
RESULTS: 675 patients were evaluated: 368 with Crohn's disease (CD) and 307 with ulcerative colitis (UC). Of these, 54.8% were boys and 45.2% were girls. There were no statistically significant differences in age, weight, height and disease activity between the CD and UC patients. The UC patients had higher BMI values than the CD patients. The prevalence of overweight and obesity was higher in the UC than the CD patients (4.89% CI95 2.76-7.93 vs. 2.45% CI95 1.12-4.59 and 8.47% CI95 5.61-12.16 vs. 1.9% CI95 0.77-3.88, respectively); the differences were statistically significant (-2.44% CI95 -5.45 to 0.49 and -6.57% CI95 -10 to -3.1, respectively). The risk of overweight/obesity was 3.5 times higher for patients with UC (OR=0.272, CI95 0.14-0.49, p=0.0004).
CONCLUSIONS: The prevalence of overweight and obesity in newly diagnosed children with IBD was 8.4% and was higher in patients with UC than in patients with CD. The results of this study have shown that not only malnourished children may suffer from IBD but also children who are overweight or obese at the time of diagnosis.
Copyright © 2015 Medical University of Bialystok. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Children; Crohn disease; Inflammatory bowel diseases; Overweight and obesity; Ulcerative colitis

Mesh:

Year:  2015        PMID: 26355738     DOI: 10.1016/j.advms.2015.07.004

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  7 in total

Review 1.  European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.

Authors:  Stephan C Bischoff; Rocco Barazzoni; Luca Busetto; Marjo Campmans-Kuijpers; Vincenzo Cardinale; Irit Chermesh; Ahad Eshraghian; Haluk Tarik Kani; Wafaa Khannoussi; Laurence Lacaze; Miguel Léon-Sanz; Juan M Mendive; Michael W Müller; Johann Ockenga; Frank Tacke; Anders Thorell; Darija Vranesic Bender; Arved Weimann; Cristina Cuerda
Journal:  United European Gastroenterol J       Date:  2022-08-12       Impact factor: 6.866

Review 2.  Regulation of intestinal immunity by dietary fatty acids.

Authors:  Jinxin Qiu; Yanhui Ma; Ju Qiu
Journal:  Mucosal Immunol       Date:  2022-07-12       Impact factor: 8.701

3.  Nutritional characteristic of children with inflammatory bowel disease in the nationwide inflammatory bowel disease registry from the Mediterranean region.

Authors:  Zarife Kuloglu; Funda Çetin; Nafiye Urgancı; Zerrin Önal; Sinan Sarı; Hasan Yüksekkaya; Gönül Çaltepe; Günsel Kutluk; Ebru Dumlupinar
Journal:  Eur J Clin Nutr       Date:  2022-02-16       Impact factor: 4.884

4.  Prevalence of pre-school children for overweight/obesity in Turkey.

Authors:  Fatih Santas; Gulcan Santas
Journal:  World J Pediatr       Date:  2018-01-15       Impact factor: 2.764

5.  Methylation of RUNX3 Promoter 2 in the Whole Blood of Children with Ulcerative Colitis.

Authors:  Emilia Dybska; Jan Krzysztof Nowak; Aleksandra Banaszkiewicz; Anna Szaflarska-Popławska; Jarosław Kierkuś; Jarosław Kwiecień; Urszula Grzybowska-Chlebowczyk; Jarosław Walkowiak
Journal:  Genes (Basel)       Date:  2022-09-01       Impact factor: 4.141

6.  Unique β-Glucuronidase Locus in Gut Microbiomes of Crohn's Disease Patients and Unaffected First-Degree Relatives.

Authors:  Karine Gloux; Jamila Anba-Mondoloni
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

7.  Body Mass Index at Presentation of Inflammatory Bowel Disease in Children.

Authors:  Fernando R Medina Carbonell; Ojasvini Choyudhry Chandan
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2020-08-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.